Multi-organ quantitative MRI for the assessment of liver disease – A whole much more than the sum of its parts
Author(s): ,
Rajeshwar P. Mookerjee
Affiliations:
University College London (UCL) Institute for Liver and Digestive Health, Division of Medicine, UCL, London, UK
,
Stuart A. Taylor
Affiliations:
University College London (UCL) Centre for Medical Imaging, Division of Medicine, UCL, London, UK
Manil D. Chouhan
Affiliations:
University College London (UCL) Centre for Medical Imaging, Division of Medicine, UCL, London, UK
Corresponding author. Address: UCL Centre for Medical Imaging, University College London, 3rd Floor East, 250 Euston Road, London NW1 2PG, UK. Tel.: +44 0203 447 9324.
EASL LiverTree™. Chouhan M. Nov 1, 2018; 234531
Manil D. Chouhan
Manil D. Chouhan
Contributions
Journal Abstract
References
This article does not have an abstract to display.
[1]. M.D. Chouhan - Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique
[2]. T.J. Bray - Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology
[3]. T. Yokoo - Fat and iron quantification in the liver
[4]. M.D. Chouhan - Vascular assessment of liver disease-towards a new frontier in MRI
[5]. C.R. Bradley - Multi organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging
[6]. S. Agrawal - Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liver disease
[7]. E.H. Wissler - Identifying a long standing error in single-bolus determination of the hepatic extraction ratio for indocyanine green
[8]. M.D. Chouhan - Use of caval subtraction 2D phase-contrast mr imaging to measure total liver and hepatic arterial blood flow: preclinical validation and initial clinical translation
[9]. C.L. Hoad - A study of T relaxation time as a measure of liver fibrosis and the influence of confounding histological factors
[10]. Chouhan MD, Ramasawmy R, Bainbridge A, Campbell-washburn A, Wells J, Punwani S, et al. Measurement of bulk liver perfusion: Assessment of agreement between ASL and caval subtraction phase-contrast MRI at 9.4T. Proc. Intl. Soc. Mag. Reson. Med., Singapore: 2016, p. 0162.
[11]. N. Palaniyappan - Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging
[12]. K.S. Lee - Corticomedullary differentiation on T1-Weighted MRI: comparison between cirrhotic and noncirrhotic patients
[13]. M. Chouhan - Phase contrast and cardiac cine MRI for non-invasive assessment of hepatic haemodynamic and cardiac systolic function in a rodent model of chronic liver disease
[14]. S. Wiese - Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
[15]. T. Sersté - Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites
[16]. F.E. Mozes - Influence of fat on liver T measurements using modified Look-Locker inversion recovery (MOLLI) methods at 3T
[17]. X. Pan - Quantification of liver perfusion using multidelay pseudocontinuous arterial spin labeling
[18]. M.D. Chouhan - Caval subtraction 2D phase-contrast MRI to measure total liver and hepatic arterial blood flow
[19]. N.C. McAvoy - Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis
[20]. N. McDonald - Assessment of haemodynamic response to nonselective beta-blockers in portal hypertension by phase-contrast magnetic resonance angiography
[21]. V.K. Snowdon - Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies